Legend Biotech Corp - COMMON STOCK (LEGN)

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COMMON STOCK
Shares outstanding
367,291,225
Total 13F shares
39,005,848
Share change
+10,676,951
Total reported value
$1,971,657,000
Put/Call ratio
88%
Price per share
$50.56
Number of holders
87
Value change
+$572,564,727
Number of buys
50
Number of sells
33

Institutional Holders of Legend Biotech Corp - COMMON STOCK (LEGN) as of Q3 2021

As of 30 Sep 2021, Legend Biotech Corp - COMMON STOCK (LEGN) was held by 87 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,005,848 shares. The largest 10 holders included HHLR ADVISORS, LTD., Capital International Investors, BAKER BROS. ADVISORS LP, ALLIANCEBERNSTEIN L.P., CAPITAL INTERNATIONAL INC /CA/, Hudson Bay Capital Management LP, FEDERATED HERMES, INC., JOHNSON & JOHNSON, Woodline Partners LP, and MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC. This page lists 87 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.